% Comprehensive NeoPKPD 6-Platform Benchmark Results
% Commercial platforms marked with * use reference data from literature
\begin{table}[!ht]
\centering
\small
\caption{Comprehensive benchmark comparison across 6 pharmacometrics platforms}
\label{tab:6platform_benchmarks}
\begin{tabular}{@{}llrrr@{}}
\toprule
\textbf{Category} & \textbf{Platform} & \textbf{Mean (ms)} & \textbf{Std} & \textbf{vs NeoPKPD} \\
\midrule
analysis & NeoPKPD (Julia) & 0.22 & 0.10 & 1.00x \\
\midrule
estimation & Monolix* & 19.25 & 4.17 & 0.00x \\
 & NONMEM* & 205.55 & 45.38 & 0.00x \\
 & NeoPKPD (Julia) & 0.00 & 0.00 & 1.00x \\
 & Pumas* & 0.02 & 0.01 & 0.16x \\
 & mrgsolve & 0.11 & 0.03 & 0.03x \\
 & nlmixr2 & 4.05 & 0.89 & 0.00x \\
\midrule
nca & Monolix* & 0.15 & 0.03 & 1.12x \\
 & NONMEM* & 19.83 & 4.43 & 0.01x \\
 & NeoPKPD (Julia) & 0.17 & 0.12 & 1.00x \\
 & Pumas* & 0.01 & 0.00 & 14.54x \\
 & mrgsolve & 0.20 & 0.06 & 0.84x \\
 & nlmixr2 & 0.14 & 0.03 & 1.18x \\
\midrule
pd & Monolix* & 2.55 & 0.52 & 0.00x \\
 & NONMEM* & 943.08 & 137.28 & 0.00x \\
 & NeoPKPD (Julia) & 0.01 & 0.01 & 1.00x \\
 & Pumas* & 0.02 & 0.01 & 0.53x \\
 & mrgsolve & 0.62 & 0.10 & 0.02x \\
 & nlmixr2 & 23.14 & 3.02 & 0.00x \\
\midrule
pk & Monolix* & 4.54 & 0.90 & 0.13x \\
 & NONMEM* & 1264.22 & 196.07 & 0.00x \\
 & NeoPKPD (Julia) & 0.60 & 0.92 & 1.00x \\
 & Pumas* & 0.69 & 0.18 & 0.86x \\
 & mrgsolve & 0.77 & 0.15 & 0.77x \\
 & nlmixr2 & 31.25 & 28.97 & 0.02x \\
\midrule
pkpd & Monolix* & 4.45 & 0.92 & 0.07x \\
 & NONMEM* & 1485.65 & 220.60 & 0.00x \\
 & NeoPKPD (Julia) & 0.31 & 0.31 & 1.00x \\
 & Pumas* & 0.48 & 0.14 & 0.65x \\
 & mrgsolve & 0.79 & 0.18 & 0.40x \\
 & nlmixr2 & 21.16 & 1.30 & 0.01x \\
\midrule
population & Monolix* & 64.93 & 13.24 & 0.59x \\
 & NONMEM* & 12464.62 & 1870.42 & 0.00x \\
 & NeoPKPD (Julia) & 38.39 & 11.82 & 1.00x \\
 & Pumas* & 44.81 & 11.66 & 0.86x \\
 & mrgsolve & 11.34 & 1.20 & 3.38x \\
 & nlmixr2 & 40.17 & 6.38 & 0.96x \\
\midrule
sensitivity & Monolix* & 12.30 & 2.52 & 0.03x \\
 & NONMEM* & 4265.45 & 637.90 & 0.00x \\
 & NeoPKPD (Julia) & 0.37 & 0.14 & 1.00x \\
 & Pumas* & 0.73 & 0.20 & 0.51x \\
 & mrgsolve & 1.43 & 0.31 & 0.26x \\
 & nlmixr2 & 64.83 & 8.17 & 0.01x \\
\midrule
tmdd & NeoPKPD (Julia) & 0.00 & 0.00 & â€” \\
\midrule
trial & Monolix* & 968.18 & 202.18 & 0.02x \\
 & NONMEM* & 95425.51 & 14843.17 & 0.00x \\
 & NeoPKPD (Julia) & 14.90 & 3.98 & 1.00x \\
 & Pumas* & 44.88 & 9.72 & 0.33x \\
 & mrgsolve & 67.19 & 15.18 & 0.22x \\
 & nlmixr2 & 2218.19 & 434.18 & 0.01x \\
\midrule
vpc & Monolix* & 1823.22 & 354.72 & 0.01x \\
 & NONMEM* & 142925.72 & 26493.23 & 0.00x \\
 & NeoPKPD (Julia) & 24.35 & 6.62 & 1.00x \\
 & Pumas* & 97.22 & 20.38 & 0.25x \\
 & mrgsolve & 149.23 & 27.72 & 0.16x \\
 & nlmixr2 & 4403.23 & 819.73 & 0.01x \\
\midrule
\bottomrule
\multicolumn{5}{l}{\footnotesize *Commercial platforms use reference data from published literature}
\end{tabular}
\end{table}
